(Q41287183)

29 September 2017

1 reference

title

Structural modifications of glycopeptide antibiotics (English)

1 reference

29 September 2017

0 references

A Malabarba

1

1 reference

29 September 2017

T I Nicas

series ordinal

2

1 reference

29 September 2017

R C Thompson

series ordinal

3

1 reference

29 September 2017

publication date

1 January 1997

1 reference

Medicinal Research Reviews

29 September 2017

published in

1 reference

29 September 2017

volume

17

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

69-137

1 reference

Resistance to vancomycin and teicoplanin: an emerging clinical problem

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

Structure, biochemistry and mechanism of action of glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

The structure and mode of action of glycopeptide antibiotics of the vancomycin group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

Conformation of A82846B, a glycopeptide antibiotic, complexed with its cell wall fragment: an asymmetric homodimer determined using NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

Mechanisms of glycopeptide resistance in enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

A40926, a new glycopeptide antibiotic with anti-Neisseria activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

Synthesis and antibacterial activity of a series of basic amides of teicoplanin and deglucoteicoplanin with polyamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

Mechanism of uptake of deglucoteicoplanin amide derivatives across outer membranes of Escherichia coli and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

Charge and lipophilicity govern the pharmacokinetics of glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

In vitro activity of the semisynthetic glycopeptide amide MDL 63,246

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

Pharmacokinetics of MDL 63,246, a new semisynthetic glycopeptide antibiotic, in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

Glycopeptide Antibiotic Activity and the Possible Role of Dimerization: A Model for Biological Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R

New glycopeptide antibiotics: II. The isolation and structures of chloroorienticins

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.41.1506

Identifiers

DOI

10.1002/(SICI)1098-1128(199701)17:1<69::AID-MED3>3.0.CO;2-R

1 reference

29 September 2017

1 reference